Newborn and prenatal genetic testing is to judge the underlying genetic disease of the newborn and fetus.
This report contains market size and forecasts of Newborn and Prenatal Genetic Testing in Global, including the following market information:
Global Newborn and Prenatal Genetic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Newborn and Prenatal Genetic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Newborn and Prenatal Genetic Testing include Perkin Elmer, Verinata Health, Sequenom, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Natera, Inc., Illumina, Inc., Ariosa Diagnostics and BGI and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Newborn and Prenatal Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Newborn and Prenatal Genetic Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Newborn and Prenatal Genetic Testing Market Segment Percentages, by Type, 2021 (%)
PCR
FISH
aCGH
NIPT
MSS
Global Newborn and Prenatal Genetic Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Newborn and Prenatal Genetic Testing Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Newborn and Prenatal Genetic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Newborn and Prenatal Genetic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Newborn and Prenatal Genetic Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Newborn and Prenatal Genetic Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Perkin Elmer
Verinata Health
Sequenom, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Natera, Inc.
Illumina, Inc.
Ariosa Diagnostics
BGI
CapitalBio MedLab